DrugPatentWatch Database Preview
Alembic Labs Company Profile
» See Plans and Pricing
What is the competitive landscape for ALEMBIC LABS, and what generic and branded alternatives to ALEMBIC LABS drugs are available?
ALEMBIC LABS has nine approved drugs.
Drugs and US Patents for Alembic Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic Labs | METRONIDAZOLE | metronidazole | TABLET;ORAL | 208681-002 | Jun 20, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
Alembic Labs | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 206958-001 | May 5, 2017 | AA | RX | No | No | Start Trial | Start Trial | ||||
Alembic Labs | BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 204891-002 | Jan 11, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
Alembic Labs | BENZONATATE | benzonatate | CAPSULE;ORAL | 040682-001 | Jul 30, 2007 | AA | RX | No | No | Start Trial | Start Trial | ||||
Alembic Labs | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 078218-002 | Jun 19, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
Alembic Labs | LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 203067-001 | May 9, 2013 | AA | RX | No | No | Start Trial | Start Trial | ||||
Alembic Labs | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 078218-001 | Apr 18, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.